Technology ID
TAB-3200
Hybridoma Cell Line D8H21, Monoclonal Antibody to the Specific Peptide-MHC Class II Complex
E-Numbers
B-021-1999-0
Lead Inventor
Germain, Ronald (NIAID)
Applications
Research Materials
Lead IC
NIAID
ICs
NIAID
Hybridoma Cell Line D8H21, as described in Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13856-61 and developed in the laboratory of Dr. Ronald Germain.
Commercial Applications
- A research material that can be used in the development of assays, validation of products or in quality control.
Competitive Advantages
- Speed up product development with NIH developed material that has already been tested and validated.
Licensing Contact: